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Malposition of the great arteries: A new 3D
echocardiographic approach
Kaled Hadeed , Sébastien Hascoet , Marianne Peyre , Yves Dulac ,
Romain Amadieu , Philippe Acar
Cardiologie pédiatrique, Hôpital des Enfants, CHU de Toulouse,
Toulouse, France
Purpose.— Geometric proﬁle of the left and right outlets as well as
position and size of the ventricular septal defects (VSD) determine
the surgical approach of malposition of the great vessels.
Aim.— To determine the ability of the 3D echocardiography (3DE)
to depict the outlet chambers in normal and pathologic situations.
Methods.— Twenty patients were prospectively enrolled [10 had
normal heart, ﬁve tetralogy of Fallot (TOF), three double outlet
right ventricle (DORV), two double discordance (DD) with VSD]. The
median age was 3.6 years (range 2months—13 years). All underwent
transthoracic 3DE (Philips, ie 33, X5-1 and X7-2). Full volume and
Live 3D acquisition were performed. Off-line analysis was performed
using a dedicated system (Qlab version 9). An asymmetry index of
the VSD was calculated by the maximal 3D diameter divided by the
minimal 3D diameter. A cut-off of 1.25 was set to distinguish ovale
and circular shape.
Results.— Mitro-aortic continuity was observed in all controls and
patients with TOF. Mitro-aortic distance was measured in patients
with DORV (36mm/m2). Septo-aortic and septo-pulmonary con-
tinuity was observed respectively in control and DD with VSD.
Distance between tricuspid and pulmonary valve was (25.7mm/m2)
in control, (54.4mm/m2) in TOF, (58.9mm/m2) in DORV, and
(17.5mm/m2) in DD. VSD was in sub-aortic position in TOF and in
3 DORV; in sub-pulmonary position in two DD. Mean size of the VSD
was 13.8mm (27.3mm/m2). Shape of the VSD was circular in all but
one DD with small oval VSD; subvalvular insertion on VSD crest was
observed in the same patient responsible of sub-pulmonary stenosis.
Conclusions.— 3DE is able to describe the outlet chambers and VSD
position and geometry. This tool could help to determine the best
surgical strategy in patients with malposition of the great vessels.
http://dx.doi.org/10.1016/j.acvd.2013.06.031
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Isolated left ventricular non-compaction:
Relationships between MRI criteria for
non-compaction and clinical events
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Karine Warin Fresseb
a Department of Cardiology, Thorax Institute, University Medical
Center, Nantes, France
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Background.— Isolated ventricular non-compaction is a congen-
ital cardiomyopathy, based on an arrest of normal embryonic
myocardium development and characterized by the presence of
a two-layered myocardial structure, with a compacted epicardial
band and a non-compacted endocardial layer of prominent trabec-
ulations. It is sometimes complicated by ventricular dysfunction and
heart failure, arrhythmias or thrombo-embolic events.
The aim of our study was to look for a potential relationship between
magnetic resonance imagery’s non-compaction extension criteria
and these clinical events.
Methods.— Between 2004 and 2013, we conducted a retrospective
study reviewing magnetic resonance imagery with diagnosis of
non-compaction. One hundred and twenty-ﬁve patients presented
magnetic resonance imagery’s non-compaction criteria but 26 of
them had another associated cardiomyopathy. Finally, 99 patients
fulﬁlled the diagnosis of isolated ventricular non-compaction and
were included in the study. Left ventricular ejection fraction, left
ventricular volumes, global left ventricular mass, compacted and
non-compacted left ventricular mass, number of non-compacted
segments and non-compaction score were measured. Non-
compaction score was the sum of the ratios of the thickness of
non-compacted to compacted myocardial layers superior to 2.3,
measured in the diastolic phase.
Results.— There was no statistical relationship between left ven-
tricular ejection fraction alteration and non-compaction score
(P = 0.57) or number of non-compacted segments (P = 0.97),
between stroke incidence and non-compaction score (P = 0.22) or
number of non-compacted segments (P = 0.96) and between ventri-
cular arrhythmias and non-compaction score (P = 0.59) and number
of non-compacted segments (P = 0.59). Conversely, we found a
signiﬁcant inverse relationship between left ventricular ejection
fraction and compacted mass (P < 0.0001) and between stroke and
compacted mass (P = 0.007).
Conclusion.— Our study did not show any association between
magnetic resonance imagery criteria of non-compaction extension
and clinical events. Conversely, we found a relationship between
compacted mass and left ventricular ejection fraction dysfunction
and the incidence of strokes, but not of ventricular arrhythmias.
These ﬁndings suggest that isolated left ventricular non-compaction
does not involve only the non-compacted part of the myocardium,
but also its compacted part.
http://dx.doi.org/10.1016/j.acvd.2013.06.032
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of Lyon Medical Center, Lyon, France
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Medical Center, Lyon, France
Aim.— The aim of this study was to assess the results of
transcatheter stent treatment of native or recurrent coarcta-
tion of the aorta in adolescents and adults, as an alternative to
surgery.
Material and methods.— Single-center study included patients
aged > 10 years with signiﬁcant recurrent or native coarctation of
the aorta. Clinical data (blood pressure, antihypertensive medica-
tions), echocardiographic (maximal aortic gradient, LV shortening
fraction), CTscan (isthmus diameter) measurements and hemo-
dynamical isthmus gradient were assessed before and after the
procedure. All procedures were performed under general anesthe-
sia.
Results.— From 2009 to 2012, eighteen patients, aged 10.8 to
49 years (mean 26), with native (6) or recurrent (12) coarc-
tation underwent transcatheter stent placement. All had high
blood pressure and 80% were given antihypertensive medica-
tions. Doppler peak systolic gradient across the coarcted segment
before procedure was 61± 16mmHg, LV hypertrophy was present
in 50% of the cases, mean LVSF was 27%. Stent was success-
fully implanted in all patients. The balloon to coarcted segment
diameter ratio was 2.5± 0.5, stents diameters ranged 34 to
45mm. Peak to peak hemodynamic gradient decreased from
25± 11 before to 3± 3mmHg after stent placement. Doppler max-
imal gradient decreased to 20± 5mmHg. Arterial hypertension
regressed or improved in 77% of the cases. Echocardiographic LV
hypertrophy persisted in only 30% of the cases. These results
maintained at mean 19-months follow-up (1month to 3 years).
Adverse events included one early femoral artery thrombosis and
one external iliac artery thrombosis, but no clinical limb ischemia
occurred.
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Conclusion.— Percutaneous stent placement for management of
native or recurrent aortic coarctation is an efﬁcient and safe
alternative to surgery, and is associated with a long term reduction
in blood pressure and LV hypertrophy.
http://dx.doi.org/10.1016/j.acvd.2013.06.033
27
Closure of huge tubular patent ductus arteriosus
using amplatzer vascular plug II or IV in premature
infants and small children under 6 kg
Alexandre Bretonneau , Claire Cornolle , Hugues Lucron ∗
Congenital and Pediatric Cardiology, Antilles, Guyane tertiary
care center for complex congenital cardiac diseases (M3C),
University Hospital of Martinique, BP 632, 97200 Fort-de-France,
Martinique, French West Indies
∗ Corresponding author.
Background.— Percutaneous closure of huge and tubular (type C)
patent ductus arteriosus remain challenging or unsuccessful in small
infants.
Aim.— To evaluate the usefulness and safety of Amplatzer vascu-
lar plug II and IV for percutaneous closure of very large ductus
arteriosus under 6 kg.
Methods.— Single-center retrospective study including all con-
secutive unselected patients (≤ 6 kg, large symptomatic ductus
arteriosus) referred to our institution over a 4 years period for per-
cutaneous closure and treated with plug II or IV. No patient was
excluded and there was no failure or surgery within the weight limit
to consider percutaneous closure (> 2.5 kg).
Results.— Seven patients were successfully treated using vascu-
lar plug II and IV without any residual shunt. Six plug II were
implanted (mean patients weight 4.3± 0.8 kg, mean ductus diame-
ter 6± 1.8mm, mean device size 8.6mm (6—14), ﬂuoroscopy time
14.8± 6.3min, occlusion rate 100%, mean follow-up 6± 2months)
including huge type C (5) and one type E (1) ductus. Mean pulmonary
artery pressure dropped from 25± 7 (17—38) mm of Hg to normal
value in all cases and there was no aortic protrusion or embolization.
One patient experienced severe but reversible pulmonary hyperten-
sion crisis in the catheter lab requiring blood transfusion. A 6mm
Amplatzer vascular plug IV was also implanted in a 4.2 kg patient
(4.8mm type D ductus, ﬂuoroscopy 10min, uneventful 8months
follow-up).
Conclusion.— Percutaneous closure of very large ductus arteriosus
is safe and effective under 6 kg. In our experience, the vascular plug
II proﬁle allows with acceptable risk to extend indication to infants
below 4 kg with huge tubular forms. This might contribute to reduce
surgical indications and in hospital morbidities and to improve cost
effectiveness. We believe that plug II could also be proposed in
the near future for closure of conical shape (type A) with similar
results.
http://dx.doi.org/10.1016/j.acvd.2013.06.034
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Background.— Cardiac catheterization procedures are being
increasingly performed in children with congenital heart disease for
diagnostic and treatment purposes. Given children’s greater sensi-
tivity to radiation and the longer life span during which radiation
health effects can develop, the ALARA principle (irradiation As Low
As Reasonably Achievable) is of peculiar importance. We report the
radiation doses and related factors for children who underwent car-
diac catheterization procedure in Toulouse children Hospital from
January to April 2013.
Methods.— We prospectively included 60 children (mean age 4 years
old, weight 2.350—59 kgs) undergoing a therapeutic (n = 55, 91.7%)
or diagnostic (n = 5, 8.3%) cardiac catheterization procedures. We
investigated the relationship between dose area product (DAP), ﬂu-
oroscopic time (FT), pulsed ﬂuoroscopic DAP, image acquisition DAP,
age, morphological parameters and double products combining FT
and weight or size or body mass index (BMI) or body surface area
(BSA). BSA was calculated according to the Mosteller formula.
Results.— The mean DAP was 20,697± 29,342mgycm2. The
mean total ﬂuoroscopic time was 24.6± 19.7min. DAP was not
signiﬁcantly different between diagnostic and therapeutic catheter-
ization (P = 0.98). Although image acquisition DAP accounted for
only 4.4± 2.4% of FT, it represented 42.5± 19.6% of DAP. DAP
was moderately although signiﬁcantly correlated with FT (r = 0.73,
P < 0.0001), BSA (r = 0.44, P = 0.0011), age (r = 0.37, P = 0.0082),
weight (r = 0.43, P = 0.002) and size (r = 0.38, P = 0.0052). DAP was
strongly associated with FT×Weight (r = 0.92, P < 0.0001), FT×BSA
(r = 0.93, P < 0.0001) and FT× Size (r = 0.91, P < 0.0001). Linear
regression analysis model involving FT×BSA to predict DAP was sig-
niﬁcant (P < 0.0001). Approximately 90% of the variance of DSA was
accounted for by this model.
Conclusion.— FT and morphological features (BSA, weight, size)
are the key parameters associated with DAP. Peculiar attention to
reduce FT and avoid unnecessary image acquisition may decrease
irradiation during catheterization in children with congenital heart
disease.
http://dx.doi.org/10.1016/j.acvd.2013.06.035
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(ACC-CHD) in a DNA bank for congenital heart
disease
Daniela Lauxa, Fanny Bajollea, Virginie Sallea, Stanilas Lyonnetb,
Damien Bonneta
a Centre de Référence Malformations Cardiaques Congénitales
Complexes (M3C)-Necker, Hôpital Necker-Enfants—Malades,
Assistance Publique des Hôpitaux de Paris, Université Paris
Descartes, Sorbonne Paris Cité, Paris, France
b Service de Génétique médicale, Hôpital
Necker-Enfants—Malades, Assistance Publique des Hôpitaux de
Paris, Université Paris Descartes, Sorbonne Paris Cité, Paris,
France
Background.— DNA banks containing samples of patients with con-
genital heart disease are being developed at international level.
The accurate anatomic description of the cardiac phenotype of such
samples is a key feature for their success.
Objective and methods.— To precisely describe the cardiac pheno-
type of the available samples of the ‘‘CARREG’’ DNA bank, started in
April 2009 in our institution, based on the recently published clin-
ical and anatomic classiﬁcation (ACC-CHD) and the International
Pediatric and Congenital Cardiac Code (IPCCC). Samples collected
